In Vitro and In Vivo Evaluation of Oral Controlled Release Formulation of BCS Class I Drug Using Polymer Matrix System.

controlled release diltiazem hydrochloride matrix system poloxamer-188 polymer

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
16 Sep 2021
Historique:
received: 09 08 2021
revised: 10 09 2021
accepted: 10 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 29 9 2021
Statut: epublish

Résumé

Diltiazem hydrochloride is a calcium channel blocker, which belongs to the family of benzothiazepines. It is commonly used to treat hypertension and atrial fibrillation. Even though the drug has high solubility, its high permeability and rapid metabolism in the liver can limit the bioavailability and increase the dose frequencies for up to four times per day. This study focused on a polymer matrix system not only to control the drug release but also to prolong the duration of bioavailability. The polymer matrices were prepared using different ratios of poloxamer-188, hydroxypropyl methylcellulose, and stearyl alcohol. In vitro and in vivo assessments took place using 24 rabbits and the results were compared to commercially available product Tildiem

Identifiants

pubmed: 34577629
pii: ph14090929
doi: 10.3390/ph14090929
pmc: PMC8470007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : College of Medicine and Health Sciences, United Arab Emirates University
ID : Research Start- up grant no: 700032854

Références

Annu Rev Chem Biomol Eng. 2010;1:149-73
pubmed: 22432577
Expert Opin Pharmacother. 2005 May;6(5):765-76
pubmed: 15934903
Expert Opin Drug Deliv. 2010 Apr;7(4):429-44
pubmed: 20331353
AAPS PharmSciTech. 2020 May 20;21(5):148
pubmed: 32436061
J Pharm Pharm Sci. 2018;21(1):398-408
pubmed: 30365396
Eur J Pharm Biopharm. 2007 Aug;67(1):211-9
pubmed: 17267193
Pharmaceuticals (Basel). 2021 May 18;14(5):
pubmed: 34070160
Drug Res (Stuttg). 2014 Mar;64(3):118-23
pubmed: 23986307
Gen Physiol Biophys. 2009;28 Spec No:149-54
pubmed: 19893093
Acta Pharm. 2019 Jun 1;69(2):197-215
pubmed: 31259729
Eur J Pharm Sci. 2018 Jul 1;119:234-243
pubmed: 29679708
Polymers (Basel). 2021 Feb 28;13(5):
pubmed: 33671032
AAPS PharmSciTech. 2017 Feb;18(1):82-92
pubmed: 26883263
Pak J Pharm Sci. 2017 Nov;30(6(Supplementary)):2329-2336
pubmed: 29188765
J Funct Biomater. 2018 Jan 18;9(1):
pubmed: 29346330
J Control Release. 2014 Sep 28;190:3-8
pubmed: 24794901
Pharm Res. 2019 Feb 19;36(4):52
pubmed: 30783816
Phys Chem Chem Phys. 2016 Aug 21;18(31):21809-16
pubmed: 27436760
Indian J Pharm Sci. 2013 Nov;75(6):619-27
pubmed: 24591735
Pharmaceutics. 2019 Mar 19;11(3):
pubmed: 30893859
Pharmaceutics. 2019 Dec 10;11(12):
pubmed: 31835628
AAPS PharmSciTech. 2017 Nov;18(8):3286-3295
pubmed: 28589306
J Pharm Sci. 2021 Dec;110(12):3907-3918
pubmed: 34403653
Int J Pharm. 2015 Dec 30;496(2):766-79
pubmed: 26561726
Pharm Res. 2017 May;34(5):890-917
pubmed: 28251425
J Orthop Res. 2004 Sep;22(5):1135-42
pubmed: 15304290
AAPS J. 2015 Nov;17(6):1327-40
pubmed: 26276218
J Pharm Pharm Sci. 2017;20(0):305-318
pubmed: 28885915
Acta Pharm. 2009 Sep;59(3):313-23
pubmed: 19819827
Front Biosci (Elite Ed). 2010 Jan 01;2(2):424-40
pubmed: 20036890
J Pharm Bioallied Sci. 2020 Oct-Dec;12(4):489-498
pubmed: 33679098
Molecules. 2017 Nov 15;22(11):
pubmed: 29140306
Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):635-645
pubmed: 27686853
Int J Pharm Investig. 2012 Jan;2(1):2-11
pubmed: 23071954
Int J Pharm. 2007 Sep 5;342(1-2):82-6
pubmed: 17580108
Int J Pharm. 2003 Jun 18;259(1-2):173-9
pubmed: 12787645
J Basic Clin Physiol Pharmacol. 2021 Jun 25;32(4):517-525
pubmed: 34214318
Pharmaceutics. 2019 Jul 16;11(7):
pubmed: 31315287
Medicines (Basel). 2018 Dec 29;6(1):
pubmed: 30597953
Polymers (Basel). 2019 May 02;11(5):
pubmed: 31052540
J Adv Pharm Technol Res. 2013 Apr;4(2):101-7
pubmed: 23833750
Eur J Pharm Sci. 2018 Jan 1;111:383-392
pubmed: 28986194
J Adv Pharm Technol Res. 2012 Oct;3(4):229-36
pubmed: 23378944
Pharmaceutics. 2019 Jun 01;11(6):
pubmed: 31159403
Int J Pharm. 2019 Feb 25;557:53-65
pubmed: 30580086
J Agric Food Chem. 2018 Oct 31;66(43):11265-11272
pubmed: 30234986
Int J Pharm. 2009 Dec 1;382(1-2):172-82
pubmed: 19716866
J Am Chem Soc. 2014 Feb 12;136(6):2212-5
pubmed: 24369096
J Cardiovasc Pharmacol Ther. 2019 Mar;24(2):193-203
pubmed: 30458627
J Biomater Sci Polym Ed. 2018 Aug;29(11):1233-1249
pubmed: 29560817
Int J Pharm. 2005 Nov 23;305(1-2):122-8
pubmed: 16226412
Recent Pat Biotechnol. 2012 Dec;6(3):200-11
pubmed: 23092436
J Control Release. 2020 Nov 10;327:834-856
pubmed: 32931897
Pak J Pharm Sci. 2018 Jan;31(1(Suppl.)):345-351
pubmed: 29386164
Langmuir. 2013 Jan 29;29(4):1045-53
pubmed: 23256509
Drug Dev Ind Pharm. 2010 Jul;36(7):832-8
pubmed: 20515404

Auteurs

Mosab Arafat (M)

College of Pharmacy, Al Ain University, Al Ain P.O. Box 64141, United Arab Emirates.

Muhammad Sarfraz (M)

College of Pharmacy, Al Ain University, Al Ain P.O. Box 64141, United Arab Emirates.

Mohammad F Bostanudin (MF)

College of Pharmacy, Al Ain University, Al Ain P.O. Box 64141, United Arab Emirates.

Anna Esmaeil (A)

College of Pharmacy, Al Ain University, Al Ain P.O. Box 64141, United Arab Emirates.

Aisha Salam (A)

College of Pharmacy, Al Ain University, Al Ain P.O. Box 64141, United Arab Emirates.

Salahdein AbuRuz (S)

Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 17666, United Arab Emirates.
Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.

Classifications MeSH